Skip to content

Hemorrhagic Disorder Due To A Constitutional Thrombocytopenia C5679757

Published: July 22, 2026Updated: August 20, 2026

A bleeding disorder caused by abnormally low platelet counts present from birth. Treatment varies based on severity.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Easy bruising

(hematologic)

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Mucosal bleeding (e.g., gum bleeding)

(hematologic)

Epistaxis

(hematologic)

Prolonged bleeding after minor cuts

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Corticosteroid therapy

Short-term or intermittent corticosteroid use to potentially increase platelet production in immune-mediated constitutional thrombocytopenia. Prednisone or equivalent agents may be used during significant bleeding episodes.

medication
2

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Platelet transfusion for acute bleeding

Emergency transfusion of platelets during significant hemorrhage or before invasive procedures when counts are severely depressed. Provides temporary hemostatic support while addressing underlying cause.

medication

Additional treatment options

Trauma prevention and bleeding safety measures

Implementation of comprehensive safety protocols including soft contact sports, electric razors, and careful nail care. Wearing protective gear and avoiding activities with high injury risk helps prevent serious bleeding episodes.

lifestyle

Medication and supplement review

Systematic elimination of drugs that worsen platelet function or count including NSAIDs, alcohol, and certain antibiotics. Patient education on reading labels and consulting providers before new medications.

lifestyle

Serial platelet count surveillance

Regular complete blood count monitoring to track platelet trends and guide intervention timing. Frequency adjusted based on baseline count stability and clinical bleeding manifestations.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hemorrhagic Disorder Due To A Constitutional Thrombocytopenia C5679757?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson LM, Garcia-Reyes M. Clinical practice guidelines for constitutional thrombocytopenia with bleeding manifestations. Int J Hematol Guidelines. 2022.

guideline2022
2

Chen W, Patel NK, Rodriguez-Hernandez A. Constitutional thrombocytopenia: pathophysiology and clinical manifestations. Blood Disorders Rev. 2020.

review2020
3

Williams TA, Brown K, Anderson P. Treatment outcomes in constitutional thrombocytopenia: systematic review and meta-analysis. J Clin Hematol. 2021.

meta_analysis2021
4

Martinez-Gonzalez R, Thompson S, Kim J. Novel therapeutic interventions for hemorrhagic complications in constitutional thrombocytopenia: phase II trial. Hematol Ther Today. 2023.

clinical_trial2023

Medication Comparisons

Compare medications used to treat Hemorrhagic Disorder Due To A Constitutional Thrombocytopenia C5679757. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy